Trials / Completed
CompletedNCT05289921
To Evaluate HU-014 in the Treatment of Post Stroke Upper Limb
Multi Center, Phase III Clinical Trial to Evaluate the Safety and Efficacy of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 198 (actual)
- Sponsor
- Huons Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Investigational Product: LIZTOX inj 100unit(HU-014) Title : Multi Center, Phase III Clinical Trial to Evaluate the efficacy and Safety of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity Sites and investigators : Asan Medical Center(Seoul), Min-ho Chun, M.D, Ph.D Objective : To evaluate the efficacy and safety of LIZTOX inj in the treatment of Post Stroke Upper Limb Spasticity
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | HU-014 Inj | HU-014 Inj was given an injection to 5 Upper limb muscle |
Timeline
- Start date
- 2022-03-04
- Primary completion
- 2023-01-03
- Completion
- 2023-03-07
- First posted
- 2022-03-22
- Last updated
- 2023-08-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05289921. Inclusion in this directory is not an endorsement.